Continuous Heterogeneous Crystallization on Excipient Surfaces-Reference-Cited by-同舟云学术

Continuous Heterogeneous Crystallization on Excipient Surfaces

Published:2017-05-16 Issue:6 Volume:17 Page:3321-3330
ISSN:1528-7483
Container-title:Crystal Growth & Design
language:en
Short-container-title:Crystal Growth & Design

Author:

Yazdanpanah Nima¹²^ORCID,Testa Christopher J.¹²,Perala Siva R. K.¹²,Jensen Keith D.¹²,Braatz Richard D.¹²,Myerson Allan S.¹²^ORCID,Trout Bernhardt L.¹²^ORCID

Affiliation:

1. Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States

2. Novartis-MIT Center for Continuous Manufacturing, Cambridge, Massachusetts 02139, United States

Funder

Novartis

Publisher

American Chemical Society (ACS)

Subject

Condensed Matter Physics,General Materials Science,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.cgd.7b00297

Reference60 articles.

1. Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control

2. Comparison of Low Shear, High Shear, and Fluid Bed Granulation During Low Dose Tablet Process Development

3. Process control and scale-up of pharmaceutical wet granulation processes: a review

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on solid-state form, crystal modification and transition issues related to tablet manufacturing;Journal of Drug Delivery Science and Technology;2024-10

2. Development of Continuous Additive-Controlled MSMPR Crystallization by DoE-Based Batch Experiments;Industrial & Engineering Chemistry Research;2024-07-23

3. Highly efficient recovery of Zn2+/Cu2+ from water by using hydrotalcite as crystal seeds;Science of The Total Environment;2024-03

4. Quality by Design (QbD) Concept for Formulation of Oral Formulations for Tablets;Introduction to Quality by Design (QbD);2024

5. FDA/M-CERSI Co-Processed API Workshop Proceedings;Journal of Pharmaceutical Sciences;2023-08